ISPE Provides New Guidance on Change Management Systems
ISPE announced the release of the ISPE APQ Guide: Change Management System. This Guide provides a quality management framework for assessing…
ISPE Announces Leaders from FDA, EMA, WHO, & AEMPS at Annual European Conference
ISPE announced six regulatory speakers for the 2022 ISPE Europe Annual Conference, taking place 25–27 April 2022 in Madrid, Spain and…
Aseptic Conference Day 2: Keynote on Microbial Quality and Emerging Leaders
Microbial quality encompasses sterility assurance—and more, as discussed by Joyce Hansen, Vice President of J&J Microbiological Quality and Sterility Assurance…
2022 ISPE Aseptic Conference Opens With Harmonization, Adaptation Presentations
The 2022 ISPE Aseptic Conference opened on Monday 14 March with keynote presentations by two regulators focusing respectively on PIC/S harmonization efforts…
ISPE Initiatives Support Supply Chain Resiliency
ISPE is a global industry leader in scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. As a result,…
Transportable Manufacturing
Imagine a time where medicines are made at your doorstep, where an illness can be treated in moments, storage conditions…
How Can the Pharmaceutical Sector Reduce Its Carbon Footprint?
All it takes is a quick Google search for the terms “carbon footprint and the pharmaceutical sector” to reveal some…
ISPE Announces 2021-2022 Board of Directors Election Results
ISPE announced the results of its 2021–2022 International Board of Directors election, revealing a slate of strategic leaders who represent…
ISPE Board Member Named One of the Top 25 Healthcare Technology CEOs of Europe for 2021
Teresa Minero Founder & CEO LifeBee - Digitalizing Life Sciences Teresa Minero, Founder and CEO of LifeBee, has been recognized…
ISPE Publishes ISPE APQ Guide: Management Responsibilities & Review (MRR)
APQ Guide: Management Responsibilities & Review (MRR)ISPE announced the release of its latest Guide, ISPE APQ Guide: Management Responsibilities and…